Supplementary Method
Equation 6 , and we take λ U = λ V = λ which represents the regularization parameter. A lower λ would introduce more complexity when building up the model. Then we minimize E with respect to u i (1 ≤ i ≤ N) and v j (1 ≤ j ≤ M)) using gradient descent method, with the help of two parameters, step size (εሻ and momentum (µ). To this end, we use the recurrence relation with step size ε:
starting from 0 1 ( ) Q E = ε∇ u . In the present computations, the parameters ε = 3, λ = 0.01, and µ = 0.9 were adopted as an optimal set to yield the highest hit ratios.
Supplementary Figures
Supplementary Figure S1 Supplementary Figure S4 . Evaluation of method performance as a function of dataset size. We evaluated the method's performance as a function of the training dataset size, displayed for the four subsets of enzymes listed in Table 2 . The fraction of the dataset used for training the model was changed from 20% to 90% and the resulting AUC was recorded. Since there is randomness in assigning data points to the train/test datasets, each step was repeated 100 times. The solid curves show the average and the dotted curves showing one standard deviation above/below the average. The dashed vertical bar indicates the fraction (80%) used for generating the AUC values listed in Table 2 In each plot, the ordinate shows the number of hits (accurately predicted hidden interactions) as a function of the number of predicted drug-target associations (abscissa). Blue, red and green solid curves refer to AL, PL, and random results and dashed curves indicate the standard deviation (see caption for Figure 5 ). The dashed orange line indicates the 100% performance limit for comparative purposes. 70% of the interactions were hidden/removed randomly at the beginning of each simulation, and computations were repeated 48 times with different selections of hidden associations. The upper panels display the results for the top-ranking 100 predictions, and the lower, for the top-ranking 1,000. Overall the AL accuracy rate increases from 50.4% to 58.7%, as we increase the dimensionality from D = 30 to 50, for m = 1,000 predictions, and the respective variances are 2.7 and 3.5%. In the case of N = 100 predictions, the AL accuracy rate increase from 70.1% to 88.0%, and the respective variances are 5.1 and 4.7%.
Supplementary Table   Table S1 : The most dominant (highest representation) therapeutic function in each cluster, and the number of drugs in that cluster. 
Cluster Number Most Dominant Therapeutic Function Number of Drugs

